Accéder au contenu
Merck

The Long Noncoding RNA UCA1 Negatively Regulates Melanogenesis in Melanocytes.

The Journal of investigative dermatology (2019-07-06)
Shiyao Pei, Jing Chen, Jianyun Lu, Shuanghai Hu, Ling Jiang, Li Lei, Yujie Ouyang, Chuhan Fu, Yufang Ding, Si Li, Liyang Kang, Lihua Huang, Hong Xiang, Rong Xiao, Qinghai Zeng, Jinhua Huang
RÉSUMÉ

The long noncoding RNA UCA1 was first discovered in bladder cancer and is known to regulate the proliferation and migration of melanoma. However, its role in melanogenesis is unclear. In this study, we aimed to explore the role and mechanism of UCA1 in melanogenesis. Our findings showed that the expression of UCA1 was negatively correlated with melanin content in melanocytes and pigmented nevus. Overexpression of UCA1 in melanocytes decreased melanin content and the expression of melanogenesis-related genes, whereas knockdown of UCA1 in melanocytes had the opposite effect. High-throughput sequencing revealed that microphthalmia-associated transcription factor (MITF), an important transcription factor affecting melanogenesis, was also negatively correlated with the expression of UCA1. Furthermore, the transcription factor CRE-binding protein (CREB), which promotes MITF expression, was negatively regulated by UCA1. The cAMP/protein kinase A (PKA), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) signaling pathways, which are upstream of the CREB/MITF/melanogenesis axis, were activated or inhibited in response to silencing or enhancing UCA1 expression, respectively. In addition, enhanced UCA1 expression downregulates the expression of melanogenesis-related genes induced by UVB in melanocytes. In conclusion, UCA1 may negatively regulate the CREB/MITF/melanogenesis axis through inhibiting the cAMP/PKA, ERK, and JNK signaling pathways in melanocytes. UCA1 may be a potential therapeutic target for the treatment of pigmented skin diseases.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-TRP1/TYRP1, clone TA99, sans azoture, clone TA99, 1 mg/mL, from mouse
Sigma-Aldrich
Anti-MiTF Antibody, clone 3D1.2, clone 3D1.2, from mouse